|
General Information
|
| Term |
neurodevelopmental disorder with spastic paraplegia and microcephaly |
ID (Ontology) |
DOID:0070542 (Human Disease) |
| Definition |
An amino acid metabolic disorder characterized delayed psychomotor development with delayed walking, moderately to severely impaired intellectual development, and poor or absent speech that has_material_basis_in homozygous or compound heterozygous mutation in the GPT2 gene on chromosome 16q11.2. Postnatal microcephaly and spastic paraplegia are also common. |
| Also Known As |
"autosomal recessive mental retardation 49" ; "glutamate pyruvate transaminase 2 deficiency" ; "GPT2 deficiency" (for all, see Synonyms field below) |
| Comment |
|
|
Links to External Ontologies
|
|
DO.org
|
|
Annotations
|
|
Records annotated with this term OR any of its CHILD TERMS
|
|
|
|
Records annotated with this exact term (annotations to child terms are NOT included)
|
|
No relevant records available
|
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
| Full annotation statements | Relevant FlyBase reports |
|---|
| Genes |
|---|
neurodevelopmental disorder with spastic paraplegia and microcephaly | 1 | for disease ribbon | neurodevelopmental disorder with spastic paraplegia and microcephaly | 1 | model of | neurodevelopmental disorder with spastic paraplegia and microcephaly | 1 |
|